Kaika Biotechnology
Latest round
- Series B
Last raised
- Oct 2022
Total raised
- $34M
Investors
- 9
About Kaika Biotechnology
In January 2022, the company passed ISO 13485:2016 certification. In May 2022, neoX has become the strategic partner of Kaika Biotechnology. The company provides its own research and development platform SAMSTM (Structure Aided design and Multiplex Screening), it focuses on delivering protein and antibody products and technologies for immune therapy and IVD customers. Its products include mRNA vaccine GMP raw material enzyme, gene editing enzyme, universal nuclease and VLP superantigen protein. The company's solutions include exclusive SPR customized detection service for MHC polypeptide complex expression, customized low endotoxin protein and customized detection service for VLP protein exclusive SPR.
Who invested in Kaika Biotechnology
9 investors across 3 rounds
See all investors in Kaika Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kaika Biotechnology
Who invested in Kaika Biotechnology?
Kaika Biotechnology has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kaika Biotechnology raised?
Kaika Biotechnology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Kaika Biotechnology last raise money?
Kaika Biotechnology's most recent round on record is a Series B, in Oct 2022.
What does Kaika Biotechnology do?
In January 2022, the company passed ISO 13485:2016 certification.
Where is Kaika Biotechnology headquartered?
Kaika Biotechnology is headquartered in Shanghai, China.
Which VCs invest in companies like Kaika Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Kaika Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Kaika Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.